Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Long-Term Investments

Bristol-Myers Squibb Company Long-Term Investments Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Long-Term Investments from 2010 to 2020.
  • Bristol-Myers Squibb Company Long-Term Investments for the quarter ending September 09, 2020 was $4,661m a 10.49% increase of 489m year over year
  • Bristol-Myers Squibb Company Long-Term Investments for the last 12 months ending September 09, 2020 was $4,661m a 10.49% increase of 489m year over year
  • Bristol-Myers Squibb Company Annual Long-Term Investments for 2019 was $4,172m a 41.30% increase of 1,723m from 2018
  • Bristol-Myers Squibb Company Annual Long-Term Investments for 2018 was $2,449m a -12.90% decrease of -316m from 2017
  • Bristol-Myers Squibb Company Annual Long-Term Investments for 2017 was $2,765m a -0.83% decrease of -23m from 2016
Other Cash Flow Metrics:
  • Bristol-Myers Squibb Company Cash Flow from Operations for the quarter ending September 09, 2018 was $1,279m a 12.67% increase of 162m year over year
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $628m a -33.89% decrease of -213m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Long-Term Investments Data

09/2020$4,661m
06/2020$4,407m
03/2020$3,795m
12/2019$4,172m
09/2019$1,499m
06/2019$1,822m
03/2019$2,003m
12/2018$2,449m
09/2018$2,917m
06/2018$2,900m

Annual BMY Long-Term Investments Data

2019$4,172m
2018$2,449m
2017$2,765m
2016$2,788m
2015$4,766m
2014$4,490m
2013$3,811m
2012$3,669m
2011$3,044m
2010$2,915m